Request more information
Available for acquisition is a differentiated, multi-platform wellness technology business operating across iOS, Android, and web. The platform is designed to help users understand and regulate day-to-day nervous-system state through a guided, body-first experience that combines a proprietary daily self-assessment, private on-device wellness measurements, a structured somatic-intervention library, and context-aware AI-supported coaching. It is positioned as a general-wellness product and is not offered as a diagnostic, treatment, or replacement for clinical care.
The company has built a substantial consumer foundation, with more than 125,000 lifetime downloads, more than 13,000 lifetime paid subscribers, availability in more than 150 countries, and a high-converting premium subscription model. Revenue is generated through consumer subscriptions across mobile and web, complemented by professional education and practitioner-channel revenue.
What distinguishes this opportunity is the asset’s evidence-supported product and data architecture. An independently reviewed real-world outcomes analysis of a large, longitudinal user cohort reported a large improvement effect on the platform’s proprietary wellness measure within the first week. The platform’s closed-loop design connects user context, optional on-device physiological readings, intervention selection, and post-intervention outcomes, creating a structured and compounding body of product intelligence.
The platform is built on fully owned mobile and cloud technology, including proprietary camera-based, on-device wellness measurement capabilities that do not require a wearable. It also includes a scalable consumer app stack, an optional smartwatch companion, AI-supported coaching infrastructure, and a professional education and practitioner-distribution platform. Operations are lean and largely automated, with no employees, no physical inventory, and a limited founder time commitment.
This is not being positioned primarily as a conventional cash-flow multiple opportunity. The seller is specifically seeking a strategic buyer that recognizes the value of the evidence-supported wellness technology platform, owned intellectual property, structured outcomes architecture, consumer subscription base, and emerging institutional and channel optionality. Potentially relevant buyers include wellness platforms, wearables and health-data companies, enterprise-benefits and employee-assistance providers, telehealth and care-navigation organizations, consumer-subscription platforms, and institutional-health technology operators.
o Evidence-Supported Wellness Platform: The business pairs a differentiated body-first intervention experience with an independently reviewed real-world outcomes analysis. Public materials should be understood as general-wellness information only; full methodology and limitations are available to qualified buyers under confidentiality.
o Closed-Loop Product and Data Architecture: The platform captures structured self-reported context, optional on-device wellness signals, intervention activity, and post-intervention feedback in one product loop. This architecture may be strategically valuable to buyers seeking a more actionable intervention layer alongside sensing, coaching, or care-navigation capabilities.
o Fully Owned Technology and IP: Included assets are expected to include the mobile and web applications, complete source code, proprietary methodology, product designs, measurement capabilities, brand-related intellectual property, domains, and associated operational systems.
o Consumer Validation and Monetization: The product has surpassed 125,000 lifetime downloads and 13,000 lifetime paid subscribers. The U.S. download-to-paid conversion rate exceeds 13%, supported by a premium subscription model and low refund experience.
o Global, Multi-Platform Distribution: The applications are available across iOS, Android, and web, with an optional smartwatch companion and users in more than 150 countries. The platform is localized for international use and benefits from a substantial organic-discovery base.
o Professional and Practitioner Channel: The business includes a professional education offering and a referral-capable practitioner ecosystem comprising hundreds of trained professionals and thousands of potential practitioner connections. This creates a B2B2C distribution pathway alongside direct consumer acquisition.
o Emerging Institutional Opportunity: The company has developed evidence and channel groundwork that may be relevant to strategic buyers evaluating institutional, employer-wellness, or government-adjacent distribution opportunities. Specific relationships, documentation, and transferability considerations will be disclosed only to qualified parties under NDA.
o Lean, Turnkey Operating Model: The business has no employees, no physical inventory, and low ongoing technology costs. The founder-operated model is largely automated and currently requires limited weekly management, offering a strategic acquirer an efficient base for integration or growth.
o Multiple Prepared Growth Levers: A buyer with distribution, marketing, enterprise-sales, or platform-integration capabilities may be able to accelerate paid acquisition, activate employer-wellness offerings, expand the practitioner channel, bundle the platform with sensing or wearable products, and develop new consented product and analytics initiatives. These are opportunities for buyer evaluation, not forecasts of future performance.
o Strategic Buyer Synergy: For a wellness, wearable, health-data, enterprise-benefits, telehealth, or consumer-subscription buyer, the platform may provide a differentiated intervention layer, owned mobile technology, a recurring-revenue consumer base, and a structured real-world outcomes foundation that would be time-consuming to reproduce organically.
The founders are prepared to provide a structured transition and training period to support a smooth handover of technology, operations, product knowledge, channel relationships, and key third-party systems. The platform has been designed for stability and low-touch operation, and a qualified buyer should be able to assume control through documented processes, focused training, and an orderly transfer plan. Extended advisory assistance may be available under separately negotiated terms.
The founders have successfully built, validated, and de-risked the platform from a product, technology, and early-channel perspective. They are now seeking to transition the business to a strategic operator better positioned to scale distribution, paid growth, enterprise or institutional channels, and product integration. The seller is prioritizing a buyer that values the platform’s evidence-supported wellness technology, owned IP, structured outcomes architecture, and strategic optionality over the current financials alone.